BOGLE INVESTMENT MANAGEMENT L P /DE/ - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 159 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
BOGLE INVESTMENT MANAGEMENT L P /DE/ ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$2,446,000
-80.8%
140,512
-80.1%
0.72%
-23.4%
Q4 2017$12,749,000
-4.1%
705,941
+2.5%
0.94%
+3.4%
Q3 2017$13,296,000
+68.1%
688,932
+2.8%
0.90%
+56.8%
Q2 2017$7,910,000
+7.7%
670,3850.0%0.58%
+12.7%
Q1 2017$7,347,000
+205.0%
670,385
+102.0%
0.51%
+208.4%
Q4 2016$2,409,000
+226.9%
331,947
+69.2%
0.17%
+219.2%
Q3 2015$737,000
-49.5%
196,193
-19.2%
0.05%
-52.3%
Q2 2015$1,459,000242,8540.11%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders